Heterodimerization between the lutropin and follitropin receptors is associated with an attenuation of hormone-dependent signaling

Endocrinology

Volumn 154, Issue 10, 2013, Pages 3925-3930

  Feng, Xiuyan ^a   Zhang, Meilin ^a   Guan, Rongbin ^a   Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL SURFACE; DIMERIZATION; HETERODIMERIZATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; CELL MEMBRANE; CHORIONIC GONADOTROPIN; DOWN-REGULATION; FLOW CYTOMETRY; FOLLICLE STIMULATING HORMONE; GREEN FLUORESCENT PROTEINS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEK293 CELLS; HUMANS; KINETICS; LUMINESCENT PROTEINS; LUTEINIZING HORMONE; PROTEIN MULTIMERIZATION; RECEPTORS, FSH; RECEPTORS, LH; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SURFACE PROPERTIES;

EID: 84884690500     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1407     Document Type: Article

References (27)

1. Dalrymple MB, Pfleger KD, Eidne KA. G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther. 2008;118:359-371.
2. Milligan G. G protein-coupled receptor dimerisation: molecular basis and relevance to function. Biochim Biophys Acta. 2007;1768:825-835.
3. Guo W, Urizar E, Kralikova M, et al. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J. 2008;27:2293-2304.
4. Sohy D, Yano H, de Nadai P, et al. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem. 2009;284:31270-31279.
5. Rozenfeld R, Devi LA. Exploring a role for heteromerization in GPCR signalling specificity. Biochem J. 2011;433:11-18.
6. Fribourg M, Moreno JL, Holloway T, et al. Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell. 2011;147:1011-1023.
7. Urizar E, Montanelli L, Loy T, et al. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J. 2005;24:1954-1964. (Pubitemid 40896167)
8. Tao YX, Johnson NB, Segaloff DL. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem. 2004;279:5904-5914. (Pubitemid 38220623)
9. Guan R, Feng X, Wu X, et al. Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J Biol Chem. 2009;284:7483-7494.
10. Guan R, Wu X, Feng X, Zhang M, Hebert TE, Segaloff DL. Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal. 2010;22:247-256.
11. Zhang M, Feng X, Guan R, Hebert TE, Segaloff DL. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization. Cell Signal. 2009;21:1663-1671.
12. Zhang M, Guan R, Segaloff DL. Revisiting and questioning functional rescue between dimerized LH receptor mutants. Mol Endocrinol. 2012;26:655-668.
13. Zhang M, Tao YX, Ryan GL, Feng X, Fanelli F, Segaloff DL. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem. 2007;282:25527-25539. (Pubitemid 47372840)
14. Mercier J-F, Salahpour A, Angers S, Breit A, Bouvier M. Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem. 2002;277:44925-44931. (Pubitemid 36159089)
15. Milligan G, Bouvier M. Methods to monitor the quaternary structure ofGprotein-coupled receptors. FEBS J. 2005;272:2914-2925. (Pubitemid 40904680)
16. Ehrlich JR, Pourrier M, Weerapura M, et al. KvLQT1 modulates the distribution and biophysical properties of HERG. A novel α-subunit interaction between delayed rectifier currents. J Biol Chem. 2004;279:1233-1241. (Pubitemid 38082647)
17. Rebois RV, Robitaille M, Gales C, et al. Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. J Cell Sci. 2006;119:2807-2818. (Pubitemid 44184017)
18. El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol. 2005;67:460-469. (Pubitemid 40216739)
19. Springael JY, Urizar E, Costagliola S, Vassart G, Parmentier M. Allosteric properties ofGprotein-coupled receptor oligomers. Pharmacol Ther. 2007;115:410-418. (Pubitemid 47362379)
20. Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol. 2009;5(9):688-695.
21. Donadeu FX, Ascoli M. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology. 2005;146:3907-3916. (Pubitemid 41175761)
22. Radu A, Pichon C, Camparo P, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med. 2010;363:1621-1630.
23. Zhang M, Shi H, Segaloff DL, Van Voorhis BJ. Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod. 2001;64:179-187. (Pubitemid 32044627)
24. Zygmunt M, Herr F, Keller-Schoenwetter S, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002;87:5290-5296. (Pubitemid 35316376)
25. Banerjee P, Fazleabas AT. Extragonadal actions of chorionic gonadotropin. Rev Endocr Metab Disord. 2011;12:323-332.
26. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
27. Mizrachi D, Shemesh M. Expression of functional luteinising hormone receptor and its messenger ribonucleic acid in bovine cervix: luteinising hormone augmentation of intracellular cyclic AMP, phosphate inositol and cyclooxygenase. Mol Cell Endocrinol. 1999;157:191-200. (Pubitemid 29505140)